https://www.linkedin.com/in/arne-astrup-a47969143/
MD, DMSc “I am excited to be part of Azento Health, as their approach for supporting GLP-1 patients is unique.”
MD, FRCP “The azh-biotics scientific platform brings an evidence-driven microbiome approach to supporting people on modern Anti-Obesity-Medications along their treatment journeys.”
https://www.linkedin.com/in/stephen-gough-415602161/
COO & CSO & Co-Founder Scientist and business leader, PhD from ETH Zurich, with CEO experience in pharma and nutrition.
Every health journey is unique. For those embarking on weight loss with GLP-1 /AOM, the path is rarely straightforward – it brings physical changes, lifestyle adjustments, and moments of challenge that test both body and mind.
We also collaborate with European obesity clinics and invest in clinical studies, real-world evidence studies and generating insights into how products are experienced by people in everyday life.
Our vision is to build a portfolio of premium products inspired by microbiome research – tailored to the evolving needs of people on modern health journeys.
At Azento Health, our work is guided by principles that go beyond products, they reflect who we are and why we exist
